Jeremy G. Chadwick

Companies

• Kymera TherapeuticsChief operating officer May 22, 2023 to now¹
• MADRIGAL PHARMACEUTICALS, INC.Sr. VP, Program Mgmt and Ops Feb 5, 2007 to Mar 3, 2010²

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

• KTKymera Therapeutics KYMR44,018 shares³$4.8M at $108.02May 27, 2026

As of each latest filing. The line shows shares held over time.

Recent filings

• May 27, 2026Sold 600 shares at $82.08 of Kymera Therapeutics³
• May 27, 2026Sold 3,679 shares at $81.50 of Kymera Therapeutics³
• May 26, 2026Sold 551 shares at $80.71 of Kymera Therapeutics³
• May 26, 2026Sold 4,500 shares at $80.02 of Kymera Therapeutics³
• May 26, 2026Sold 3,800 shares at $79.39 of Kymera Therapeutics³
• May 26, 2026Sold 324 shares at $79.17 of Kymera Therapeutics³
• May 26, 2026Sold 3,730 shares at $78.36 of Kymera Therapeutics³
• Apr 22, 2026Sold 300 shares at $90.00 of Kymera Therapeutics⁴
• Apr 22, 2026Exercised options 200 shares at $43.50 of Kymera Therapeutics⁴
• Apr 22, 2026Exercised options 100 shares at $30.17 of Kymera Therapeutics⁴
• Apr 15, 2026Sold 1,300 shares at $90.00 of Kymera Therapeutics⁵
• Apr 15, 2026Exercised options 1,300 shares at $43.50 of Kymera Therapeutics⁵
• Apr 14, 2026Sold 5,251 shares at $90.00 of Kymera Therapeutics⁵
• Apr 14, 2026Exercised options 785 shares at $43.50 of Kymera Therapeutics⁵
• Apr 14, 2026Exercised options 4,466 shares at $30.17 of Kymera Therapeutics⁵
• Apr 1, 2026Sold 1,100 shares at $86.05 of Kymera Therapeutics⁶
• Apr 1, 2026Sold 13,540 shares at $85.41 of Kymera Therapeutics⁶
• Apr 1, 2026Exercised options 14,640 shares at $29.64 of Kymera Therapeutics⁶
• Mar 31, 2026Sold 7,600 shares at $85.38 of Kymera Therapeutics⁶
• Mar 31, 2026Exercised options 7,600 shares at $29.64 of Kymera Therapeutics⁶
• Mar 25, 2026Sold 24,727 shares at $80.26 of Kymera Therapeutics⁷
• Mar 25, 2026Exercised options 24,727 shares at $29.64 of Kymera Therapeutics⁷
• Mar 23, 2026Sold 1,200 shares at $80.05 of Kymera Therapeutics⁷
• Mar 23, 2026Sold 6,105 shares at $79.87 of Kymera Therapeutics⁷
• Mar 23, 2026Sold 8,214 shares at $78.40 of Kymera Therapeutics⁷